Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2022 | Leukemic cell birth rate & the role of recently divided B cells in CLL

Nicholas Chiorazzi • 7 Oct 2022
ERIC 2022
Chronic Lymphocytic Leukemia Leukemia

Nicholas Chiorazzi, MD, Feinstein Institute for Medical Research, Manhasset, NY, discusses the association between leukemic cell birth rate and patient outcomes in chronic lymphocytic leukemia (CLL), commenting on the impact of recently divided B cells on disease evolution. Prof. Chiorazzi explains that these recently divided B cells are able to communicate with T cells to induce B cell survival and prevent the generation of cytolytic T cells. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Nicholas Chiorazzi

1:00
Identifying new CLL therapeutic targets by focusing on the evolution of cancer cells
Nicholas Chiorazzi • 7 Oct 2022
1:02
Obstacles to achieving a cure in CLL
Nicholas Chiorazzi • 7 Oct 2022
3:56
Updates on cellular and molecular interactions in the CLL microenvironment
Nicholas Chiorazzi • 18 Sep 2021
4:25
The role of AID in CLL
Nicholas Chiorazzi • 18 Sep 2021

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals